P
Procyrion
Health Tech & Medtech · Houston, United States · Founded 2005
Developing catheter-based circulatory support technologies to address a significant unmet clinical need for CHF patients MoreLess
Procyrion is a medical device company based in Houston, Texas, that is developing a novel treatment for patients with heart failure. The company's flagship product, Aortix™, is a catheter-deployed circulatory assist device designed to be minimally invasive. It is specifically targeted at the significant portion of heart failure patients who are no longer responsive to medical therapy.
The Aortix™ device is a small, powerful pump mounted on a self-expanding anchor. It is placed in the descending thoracic aorta via a catheter, a procedure that can be performed in a catheterization laboratory. Once in place, the device works by reducing the afterload on the heart, which is the resistance the heart must overcome to pump blood. This allows the heart to rest and heal, while simultaneously improving blood flow to vital organs like the kidneys.
The company is focused on addressing the unmet needs of a large and growing patient population. Heart failure is a chronic and progressive disease that affects millions of people worldwide. Procyrion's technology has the potential to provide a new treatment option for these patients, improving their quality of life and reducing the high costs associated with their care. The company is currently in the clinical trial phase, gathering data to support the safety and efficacy of its device.
Keywords: medical device, cardiology, heart failure, circulatory support, catheter-based, renal impairment, Aortix, minimally invasive, afterload reduction, clinical trials
Company overview
Procyrion company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2005
- Headquarters
- Houston, United States
- Employees
- 25
- Open positions
- None listed
- Dealroom signal
- 31.5
Valuation & funding
Procyrion funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES EOther financing | Feb 2024 | $58M | $231M | Fannin Partners · BlueBird Merchant Ventures | ↗ |
| SERIES DOther financing | Jul 2019 | $30M | $120M | BlueBird Merchant Ventures | — |
| SERIES COther financing | Jan 2018 | $16M | $64M | Jefferson River Capital · Scientific Health Development Partners · Aquinas | — |
| SERIES BOther financing | Oct 2015 | $10M | $40M | Scientific Health Development Partners | — |
| EARLY VCOther financing | Jul 2015 | $5.2M | $21M | Houston Angel Network | — |
| SEEDOther financing | Dec 2014 | Undisclosed | — | ||
| SERIES AOther financing | Feb 2013 | Undisclosed | — |
Growth signals
Procyrion website traffic
Latest recorded traffic for Procyrion is 2.4K monthly website visits, up 4.3% over the last three months. Procyrion's team declined 16.7% over the past year.
Comparisons
Procyrion compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Procyrion's talent
Source: Dealroom Talent Intelligence.
Investors
6 investors on Procyrion's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Procyrion has talent and traffic
team presence
In the news
Latest news about Procyrion
Recent press, funding announcements, and product moves mentioning Procyrion — open to read from the original sources.
Market sentiment
What the market is saying about Procyrion
An AI-synthesized read of the highest-engagement posts about Procyrion on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Procyrion’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.